Skip to content
← All Essentials

Essentials · Evidence reviewed

What should you do if your weight-loss medicine seems to stop working?

Many people experience a period when the scale stops moving even though they continue their prescription. Before calling the medication ineffective, it helps to distinguish a normal slowing of weight loss from issues such as missed doses, a change in health, or a treatment response that needs clinical review.

What counts as a real slowdown?

Body weight varies with hydration, food and bowel habits. Researchers studying tirzepatide plateaus looked at changes over 12-week windows, not a single disappointing weigh-in. Track trends consistently over time.

Why can weight loss become slower?

As body weight changes, energy needs and physiology can change too. Trial weight-loss trajectories often become less steep over time, even among participants who continue treatment. A plateau is not proof of nonadherence or failure.

Could your medication plan matter?

The dose, missed injections, tolerability, concurrent medicines and other health issues can affect the bigger picture. A clinician can determine whether the current treatment is providing benefits and whether an adjustment is supported by labeling.

What else can you measure?

Consider whether weight, waist measurements, mobility, blood pressure, glucose or other clinician-recommended markers have changed. Not every treatment benefit is reflected by the scale alone.

What is a sensible next step?

Bring several weeks of weight records, medication dates, adverse effects and questions to your prescriber. Do not double doses, combine prescription medicines or order unapproved alternatives in an attempt to restart weight loss.

The bottom line

An extended plateau is a reason to review treatment goals and options—not to improvise a dose change.

About this article

Written and published by MyDosePro as an educational explanation of publicly available evidence. The linked primary source is dated 2025-02-01. We identify trial registrations separately from published results and do not provide individual prescribing advice.

Our editorial standards →

Primary source

Tirzepatide weight plateau analysis ↗

This guide explains published evidence; source dates may be older than the review date. Our interpretation is educational and does not replace medical or insurance advice.